Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-STAR: Budesonide and Olfactory Training for Post-COVID Anosmia
NCT04422275Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of EPI-EE in anosmia, sponsored by Washington University School of Medicine. Planned start Jun 2021; status: withdrawn.
02
Drugs
EPI-EE
03
Conditions
anosmia
Beyond the preview
Go deeper on NCT04422275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04422275.